Neoplasms

Showing 26 - 50 of 928

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumors Trial in Beijing ([68Ga]P3)

Recruiting
  • Neoplasms
  • Beijing, Beijing, China
    Peking University First Hospital
Jul 4, 2023

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Orthopedic Oncology Surgery: Navigation, Intraoperative Imaging

Recruiting
  • Neoplasms
  • Muscle Neoplasm
  • evaluate the quality of surgical margins achievable with the use of navigated Intraoperative CT
  • Rome, Italy
    "Regina Elena" National Cancer Institute
Jun 15, 2023

Right-sided Hemicolectomy for Chldren With High-risk

Recruiting
  • Neoplasms
  • Appendix Cancer
    • Amsterdam-Zuidoost, Netherlands
      Amsterdam UMC
    Jun 23, 2023

    Early On-treatment Transcriptional Profiling as Predictor of

    Recruiting
    • HER2-positive Breast Cancer
    • +2 more
    • Trastuzumab (neoadjuvant)
    • +2 more
    • Hospitalet de Llobregat, Barcelona, Spain
      Institut Català d'Oncologia l'Hospitalet
    Jun 12, 2023

    Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic

    Not yet recruiting
    • Neoplasms
    • Questionnaires
    • Strasbourg, France
      Institut de cancérologie Strasbourg Europe
    Jun 16, 2023

    Tumors, Hematologic Tumors, Hematologic Diseases Trial in Xuzhou (RD13-02 cell infusion)

    Recruiting
    • Neoplasms
    • +2 more
    • RD13-02 cell infusion
    • Xuzhou, Jiangsu, China
      Affiliated hospital of Xuzhou medical college
    Jun 7, 2023

    Tumors, Esophageal Tumors, Esophagus Tumor Trial run by the National Cancer Institute (NCI) (Nivolumab, Entinostat, Montanide(R)

    Not yet recruiting
    • Neoplasms
    • +5 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jun 16, 2023

    Tumors, Hematologic Tumors, Hematologic Diseases Trial in Hefei (RD13-02 cell infusion)

    Recruiting
    • Neoplasms
    • +2 more
    • RD13-02 cell infusion
    • Hefei, Anhui, China
      The First Affiliated Hospital of University of Science and Techn
    Jun 5, 2023

    Tumors, Hematologic Tumors, Tumors by Site Trial in Wuhan (RD13-02 cell infusion)

    Recruiting
    • Neoplasms
    • +3 more
    • RD13-02 cell infusion
    • Wuhan, Hubei, China
      Union Hospital, Huazhong University of Science and Technology
    Jun 8, 2023

    Physical Activity, Tumors, Cancer Trial in Chapel Hill (Core, Simplified Nutrition Monitoring (Green), Behavioral: Simplified

    Not yet recruiting
    • Physical Activity
    • +2 more
    • Core
    • +8 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center
    Jun 5, 2023

    Tumors Trial in Beijing ([68Ga]P3)

    Recruiting
    • Neoplasms
    • Beijing, Beijing, China
      Peking University First Hospital
    Jun 4, 2023

    Tumors Trial (ABN401)

    Not yet recruiting
    • Neoplasms
    • (no location specified)
    May 21, 2023

    Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Tumors Trial in Melbourne

    Not yet recruiting
    • Cutaneous Squamous Cell Carcinoma
    • +3 more
    • Melbourne, Victoria, Australia
      Peter MacCallum Cancer Centre
    May 17, 2023

    PRediction Of Five Usual Tumors Using Blood Test for Risk

    Not yet recruiting
    • Neoplasms
    • Cancer
    • Multi-cancer early detection test
    • Guangzhou, Guangdong, China
      The Sixth Affiliated Hospital of Sun Yat-sen University
    May 16, 2023

    Tumors Trial in Bengbu (The test olaparib tablet (T), The reference olaparib tablet (R))

    Completed
    • Neoplasms
    • The test olaparib tablet (T)
    • The reference olaparib tablet (R)
    • Bengbu, Anhui, China
      The First Affiliated Hospital of Bengbu Medical College
    May 15, 2023

    Blood Cell RNA-Based Cancer Detection

    Recruiting
    • Neoplasms
    • Cancer
    • Blood test
    • Wuhan, Hubei, China
      Zheng Wang
    Apr 20, 2023

    Tumors, Chemo-induced Nausea and Vomiting Trial (eSSET-CINV)

    Not yet recruiting
    • Neoplasms
    • Chemotherapy-induced Nausea and Vomiting
    • eSSET-CINV
    • (no location specified)
    Apr 20, 2023

    Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma

    Not yet recruiting
    • Lymphoma, B-Cell
    • +6 more
    • Plasma metabolomic profile by Ultra-high performance liquid chromatography with quadrupole time-of-flight mass spectrometry (UPLC-QTOFMS)
    • Guayaquil, Guayas, Ecuador
      Instituto Oncológico Nacional Dr. Juan Tanca Marengo
    Apr 27, 2023

    Tumors Trial in Hong Kong (Ovarian tissue freezing and subsequent auto-transplantation after thawing)

    Not yet recruiting
    • Neoplasms
    • Ovarian tissue freezing and subsequent auto-transplantation after thawing
    • Hong Kong, Hong Kong
      Prince of Wales Hospital
    Apr 14, 2023

    Hematologic Diseases, Tumors Trial in Hangzhou (CD7 CAR-T cells injection, Allogeneic hematopoietic stem cell transplantation)

    Recruiting
    • Hematologic Diseases
    • Neoplasms
    • CD7 CAR-T cells injection
    • Allogeneic hematopoietic stem cell transplantation
    • Hangzhou, Zhejiang, China
      The first affiliated hospital of medical college of zhejiang uni
    Apr 11, 2023

    Tumors, Malnutrition Trial (Taste session of five ONS flavors)

    Not yet recruiting
    • Neoplasms
    • Malnutrition
    • Taste session of five ONS flavors
    • (no location specified)
    Mar 31, 2023

    Respiratory Tract Diseases, Tumors, Tumors by Histologic Type Trial run by the National Cancer Institute (NCI) (Bevacizumab)

    Not yet recruiting
    • Respiratory Tract Diseases
    • +14 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 10, 2023

    Tumors Trial in Xi'an (Fosaprepitant Dimeglumine for Injection)

    Recruiting
    • Neoplasms
    • Fosaprepitant Dimeglumine for Injection
    • Xi'an, Shaanxi, China
      The First Affiliated Hospital of Air Force Military Medical Univ
    Feb 22, 2023

    Rectal Tumors, Ostomy, Tumors Trial in Ufa (Laparoscopic or open low-anterior resection of the rectum with TME and created loop

    Not yet recruiting
    • Rectal Neoplasms
    • +2 more
    • Laparoscopic or open low-anterior resection of the rectum with TME and created loop transverse colostomy
    • Laparoscopic or open low-anterior resection of the rectum with TME and created loop ileostomy
    • Ufa, Republic Of Bashkortostan, Russian Federation
      Republican clinical oncological dispencery
    Feb 23, 2023